| 05/04/2026 1:39 PM | Invus Global Management, LLC (2005369) Filed by Tango Therapeutics (1819133) Subject | Form SCHEDULE 13G/A | |
| 05/01/2026 4:26 PM | Lee Sung (1793200) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 3:48 PM | Crystal Adam (1825445) Reporting Tango Therapeutics (1819133) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/24/2026 3:15 PM | Gall Matthew (1816194) Reporting Tango Therapeutics (1819133) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/24/2026 3:15 PM | Newcomb Jessica (2130408) Reporting Tango Therapeutics (1819133) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/17/2026 6:42 AM | Tango Therapeutics (1819133) Filer | Form DEFA14A | |
| 04/17/2026 6:44 AM | Tango Therapeutics (1819133) Filer | Form ARS | |
| 04/17/2026 6:12 AM | Tango Therapeutics (1819133) Filer | Form DEF 14A | |
| 04/16/2026 7:14 PM | Crystal Adam (1825445) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 8:19 AM | Tango Therapeutics (1819133) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/02/2026 7:09 PM | Crystal Adam (1825445) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TNGX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tango Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/27/2026 7:06 PM | Crystal Adam (1825445) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/25/2026 3:24 PM | Crystal Adam (1825445) Reporting Tango Therapeutics (1819133) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 3:52 PM | Crystal Adam (1825445) Reporting Tango Therapeutics (1819133) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 6:30 AM | Tango Therapeutics (1819133) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/05/2026 6:10 AM | Tango Therapeutics (1819133) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/05/2026 6:15 AM | Tango Therapeutics (1819133) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/27/2026 5:54 PM | Crystal Adam (1825445) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 5:29 PM | EcoR1 Capital, LLC (1587114) Filed by Tango Therapeutics (1819133) Subject | Form SCHEDULE 13G/A | |
| 02/13/2026 10:47 AM | Invus Global Management, LLC (2005369) Filed by Tango Therapeutics (1819133) Subject | Form SCHEDULE 13G/A | |
| 02/12/2026 8:11 AM | Adage Capital Management, L.P. (1535978) Filed by Tango Therapeutics (1819133) Subject | Form SCHEDULE 13G | |
| 02/06/2026 3:11 PM | FARALLON PARTNERS L L C/CA (1040153) Filed by Tango Therapeutics (1819133) Subject | Form SCHEDULE 13G/A | |
| 02/04/2026 7:09 PM | Tango Therapeutics (1819133) Issuer Weber Barbara (1800670) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 7:12 PM | Beckman Daniella (1513422) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 7:02 PM | Crystal Adam (1825445) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/30/2026 1:44 PM | Tango Therapeutics (1819133) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G | |
| 01/21/2026 11:30 AM | BlackRock, Inc. (2012383) Filed by Tango Therapeutics (1819133) Subject | Form SCHEDULE 13G | |
| 01/12/2026 5:15 AM | Peters Malte (1876563) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/08/2026 8:10 AM | Tango Therapeutics (1819133) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/06/2026 3:05 PM | Lee Sung (1793200) Reporting Tango Therapeutics (1819133) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 01/05/2026 6:09 AM | Tango Therapeutics (1819133) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/10/2025 11:15 PM | Tango Therapeutics (1819133) Filer | Form EFFECT | |
| 11/21/2025 3:15 PM | Tango Therapeutics (1819133) Subject Third Rock Ventures IV, L.P. (1688327) Filed by | Form SCHEDULE 13D/A | |
| 11/21/2025 7:31 AM | Tango Therapeutics (1819133) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 11/21/2025 7:34 AM | Tango Therapeutics (1819133) Filer | Form S-3ASR | |
| 11/21/2025 7:36 AM | Tango Therapeutics (1819133) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/13/2025 8:00 AM | Adage Capital Management, L.P. (1535978) Filed by Tango Therapeutics (1819133) Subject | Form SCHEDULE 13G/A | |
| 11/12/2025 11:17 AM | Farallon Capital Partners, L.P. (1175707) Filed by Tango Therapeutics (1819133) Subject | Form SCHEDULE 13G/A | |
| 11/04/2025 8:25 AM | Peters Malte (1876563) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2025 8:09 AM | Tango Therapeutics (1819133) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/04/2025 8:10 AM | Tango Therapeutics (1819133) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
| 10/28/2025 9:15 AM | Tango Therapeutics (1819133) Filer | Form D Notice of Exempt Offering of Securities | |
| 10/27/2025 3:15 PM | Tango Therapeutics (1819133) Issuer Third Rock Ventures GP IV, L.P. (1688326) Reporting Third Rock Ventures IV, L.P. (1688327) Reporting TRV GP IV, LLC (1688325) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:17 AM | Tango Therapeutics (1819133) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/24/2025 5:06 AM | Tango Therapeutics (1819133) Filer | Form 424B5 | |
| 10/23/2025 4:10 PM | Tango Therapeutics (1819133) Subject Third Rock Ventures IV, L.P. (1688327) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/23/2025 6:36 AM | Tango Therapeutics (1819133) Subject | Form FWP | |
| 10/23/2025 6:04 AM | Tango Therapeutics (1819133) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/29/2025 3:15 PM | Tango Therapeutics (1819133) Issuer Third Rock Ventures GP IV, L.P. (1688326) Reporting Third Rock Ventures IV, L.P. (1688327) Reporting TRV GP IV, LLC (1688325) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/25/2025 3:58 PM | Tango Therapeutics (1819133) Subject Third Rock Ventures IV, L.P. (1688327) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/22/2025 4:22 PM | Invus Global Management, LLC (2005369) Filed by Tango Therapeutics (1819133) Subject | Form SCHEDULE 13G | |
| 09/17/2025 5:06 PM | Tango Therapeutics (1819133) Issuer Third Rock Ventures GP IV, L.P. (1688326) Reporting Third Rock Ventures IV, L.P. (1688327) Reporting TRV GP IV, LLC (1688325) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/17/2025 9:29 AM | Tango Therapeutics (1819133) Subject Third Rock Ventures IV, L.P. (1688327) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/09/2025 3:15 PM | Tango Therapeutics (1819133) Issuer Third Rock Ventures GP IV, L.P. (1688326) Reporting Third Rock Ventures IV, L.P. (1688327) Reporting TRV GP IV, LLC (1688325) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/08/2025 4:22 PM | Tango Therapeutics (1819133) Subject Third Rock Ventures IV, L.P. (1688327) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/05/2025 5:08 PM | Tango Therapeutics (1819133) Subject Third Rock Ventures IV, L.P. (1688327) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/26/2025 3:15 PM | Tango Therapeutics (1819133) Issuer Third Rock Ventures GP IV, L.P. (1688326) Reporting Third Rock Ventures IV, L.P. (1688327) Reporting TRV GP IV, LLC (1688325) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 3:06 PM | Tango Therapeutics (1819133) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/22/2025 4:26 PM | Tango Therapeutics (1819133) Subject Third Rock Ventures IV, L.P. (1688327) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/21/2025 3:15 PM | Tango Therapeutics (1819133) Issuer Third Rock Ventures GP IV, L.P. (1688326) Reporting Third Rock Ventures IV, L.P. (1688327) Reporting TRV GP IV, LLC (1688325) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/19/2025 6:25 PM | Tango Therapeutics (1819133) Subject Third Rock Ventures IV, L.P. (1688327) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/12/2025 8:06 AM | Adage Capital Management, L.P. (1535978) Filed by Tango Therapeutics (1819133) Subject | Form SCHEDULE 13G | |
| 08/05/2025 6:06 AM | Tango Therapeutics (1819133) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/05/2025 6:10 AM | Tango Therapeutics (1819133) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/17/2025 7:12 PM | BlackRock, Inc. (2012383) Filed by Tango Therapeutics (1819133) Subject | Form SCHEDULE 13G | |
| 06/13/2025 4:25 PM | Farallon Capital Partners, L.P. (1175707) Filed by Tango Therapeutics (1819133) Subject | Form SCHEDULE 13G | |
| 06/09/2025 4:47 PM | Ketchum John B (1991806) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 4:47 PM | Rothenberg Mace (1873988) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 4:50 PM | Calhoun Lesley Ann (1730866) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 4:51 PM | Peters Malte (1876563) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 4:45 PM | Borisy Alexis (1319446) Reporting Tango Therapeutics (1819133) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/21/2025 11:15 PM | Tango Therapeutics (1819133) Filer | Form EFFECT | |
| 05/12/2025 6:06 AM | Tango Therapeutics (1819133) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/12/2025 6:10 AM | Tango Therapeutics (1819133) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |